Gladstone NOW: The Campaign Join Us on the Journey ✕
76 - 90 of 122 Results Clear All
BioMotiv and Cure Network Dolby Acceleration Partners collaborate to advance the development of better treatments for brain disorders
Corporate Liaison and Ventures Business Development News Release Alzheimer’s Disease Epilepsy Neurological Disease Palop Lab
The path to medical breakthroughs lies in bold, ambitious science
Donor Stories Institutional News Spinal Cord Injuries Alzheimer’s Disease Diabetes Roddenberry Stem Cell Center Bruneau Lab Ding Lab Huang Lab McDevitt Lab
Gladstone and Google AI collaborate to uncover the tip of an iceberg that could transform biomedical science
New insights into how a gene causes damage could impact future drug development
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Huang Lab
Transplanting a special type of neuron into the brain restores cognitive functions in Alzheimer’s models
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Mucke Lab Palop Lab
Study will use innovative technology to focus on neurodegenerative diseases
Business Development News Release Alzheimer’s Disease Finkbeiner Lab
Gladstone scientists receive funding to develop new drugs to reduce tau levels in the brain
Assay Development and Drug Discovery Core Alzheimer’s Disease Mucke Lab
Scientists develop a cheaper, quicker, and more reliable stem cell–based technology to facilitate drug discovery
Gan Lab Stem Cells/iPSCs Alzheimer’s Disease
A new center at Gladstone aims to find unforeseen uses for existing drugs
Huang Lab Stem Cells/iPSCs Alzheimer’s Disease
E-Scape Bio, a Gladstone spin-off company, extends its Series A financing to generate novel therapies to treat neurodegenerative disorders
Huang Lab Mahley Lab Alzheimer’s Disease
Gladstone scientists combine expertise in Alzheimer’s research with legacy as leaders in stem cell technology
Alzheimer’s Disease Gan Lab Huang Lab CRISPR/Gene Editing Stem Cells/iPSCs
Scientists discover an enzyme that that could be targeted to treat both Alzheimer’s disease and frontotemporal dementia.
Alzheimer’s Disease Finkbeiner Lab
Gladstone scientists discover how to control the cacophony of electrical activity in the brain, stopping seizures and reducing deficits related to Alzheimer’s disease.
Alzheimer’s Disease Epilepsy Mucke Lab Paz Lab Optogenetics
Scientists at the Gladstone Institutes take a comprehensive approach to dementia research, pursuing several potential causal factors of the disease in the hopes of discovering breakthrough treatments.
Alzheimer’s Disease Gan Lab Huang Lab Mucke Lab
Scientists at the Gladstone Institutes have discovered how the major genetic risk factor for Alzheimer’s disease causes memory impairment.
Alzheimer’s Disease Huang Lab
